Cambium Bio Limited has released a press release.
Appendix 4C - Quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Cambium Bio
- Regeneus partners with Defence to treat combat casualties
- Regeneus to be granted key Progenza patent in Europe
- Regeneus Company Update Investor Webcast Presentation
- Half-Year Results and Business Update
- Appendix 4D and Half-Year Report
Later from Cambium Bio
- Regeneus Announces Institutional Placement
- Regeneus Market Update
- Grant of ASX Waiver
- Preliminary Final Report
- Notice of Termination of Kyocera Licence
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio